A randomized clinical research study looked at the effectiveness of a
new treatment for stroke. The study involved adding a minimally invasive
clot removal procedure called stent thrombectomy to standard
clot-dissolving therapy, known as tissue plasminogen activator. The
study showed a dramatic improvement in restoring blood flow back to the
brain, which is critical in the recovery of stroke.
Senior (stock image). The addition of stent
thrombectomy to standard clot-dissolving treatment led to 71 percent of
patients returning to independent living, compared with 40 percent in
the standard treatment group.
Credit: © Barabas Attila / Fotolia
No comments:
Post a Comment